Predicted Impact of Mass Drug Administration on the Development of Protective Immunity against Schistosoma haematobium

• Kate M. Mitchell ,

  * E-mail: Kate.Mitchell@lshtm.ac.uk

  Current address: Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom

  Affiliation Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Francisca Mutapi,

  Affiliation Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Takafira Mduluza,

  Affiliations Department of Biochemistry, University of Zimbabwe, Harare, Zimbabwe, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa

  ⨯
• Nicholas Midzi,

  Current address: Department of Medical Microbiology, University of Zimbabwe, Harare, Zimbabwe

  Affiliation National Institute of Health Research, Harare, Zimbabwe

  ⨯
• Nicholas J. Savill,

  Affiliation Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Mark E. J. Woolhouse

  Affiliation Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom

  ⨯